Table 1: Study Subject Characteristics.

Mean Age (range) Mean Age (range) 57.4 years (40-73 years)
Male Gender (%) 26 (81%)
Race 24 Caucasian;
3 African American;
2 Hispanic;
3 other
Mean Disease Duration (range) 9.7 years (0.5-31 years)
Index Joint 1st MTP: 25 (78.1%);
Ankle: 4 (12.5%);
Elbow: 2 (6.3%)
Mid-tarsal: 1 (1.4%)
Mean # of Attacks in Index Joint 9.2 (+/- 10.2 SD)
Joint Involved with First Attack of Gout 1st MTP: 26 (81.3%);
Knee: 1 (3.3%);
Ankle: 2 (6.3%);
Elbow: 1 (3.3%);
Finger: 1 (3.3%);
Mid-tarsal: 1 (3.3%)
Mean # of Attacks in Any Joint (range) 20.3 (+/- 26.4 SD)
Currently Taking Urate Lowering Therapy 9 (28.1%)*
Currently Taking Daily Colchicine 6 (18.8%)
Currently Taking Daily NSAID 3 (9.4%)
MSU Crystal Proven Gout 15 (46.9%)
# of Patients with Subcutaneous Tophus/Tophi on physical examination 9 (28.1%)

*All subjects on urate lowering therapy at baseline were taking allopurinol.